Menu

CPTR 2017 Workshop Highlights

CPTR members and TB stakeholders reflect on the breadth and value of CPTR and its annual Workshop.

Perspectives

Tiong Xun Ting on Battling MDR-TB

Challenges to diagnosis and treatment

CPTR Data Sharing Tools: TB-PACTS & ReSeqTB

Info about and how to participate in TB-PACTS and ReSeqTB

CPTR: Workshop 2016 Highlights

Washington DC, April 4-7

News

2018 Critical Path to TB Drug Regimens (CPTR) Annual Workshop, to be held April 23-25, 2018, in Washington, DC.

Please mark your calendar for the 2018 Critical Path to TB Drug Regimens (CPTR) Annual Workshop.

October 17, 2017 Uncategorized

Summary of CPTR – NIAID 2017 Joint Workshop

On September 11 and 12, CPTR and NIAID held a joint workshop to develop a preclinical roadmap to guide advancement of entirely novel regimens, and consider how the principles of a rigorous, data-driven roadmap can contribute to the development of treatment courses that may include sequential combinations of existing and emerging drugs to lead to shorten […]

October 17, 2017 Drug Development Events animal models biomarkers drug development mouse model

From the Working Groups

Modeling & Simulation Workgroup (M&S-WG) Q4-2015 Update

Working closely with the Data Standards and Integration Workgroup (DSI-WG), the M&S-WG uses aggregated clinical trial data to create robust empirical, mechanistic, and systems biology models and quantitative simulation tools to facilitate TB drug and drug regimen development.

January 22, 2016

Data Standards & Integration Workgroup (DSI-WG) Q4-2015 Update

The DSI-WG provides the information technology (IT) infrastructure to support all CPTR data needs for developing regulatory science tools and methods to enable development of new TB drugs, drug regimens, and diagnostics. Aggregating all relevant data in a secure database for analysis by the CPTR Workgroups and authorized researchers is a key focus for this […]

January 22, 2016

Pre-Clinical and Clinical Sciences Workgroup (PCS-WG) Q4-2015 Update

The PCS-WG is focused on the evidence-based evaluation of translational tools to support effective decision-making and advance new agents from the pre-clinical to clinical development space.  These tools represent innovative approaches to address pre-clinical issues, including pre-clinical in vitro and in vivo efficacy, pre-clinical drug safety, and toxicology, pre-clinical PK/PD analyses involving the use of […]

January 22, 2016
About CPTR

Through partnership, CPTR speeds the development of new and markedly improved drug regimens for tuberculosis.